OBLN - Obalon Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $7.33. This is a potential upside of $7.33 (0%) from yesterday's end of day stock price of $0.

Obalon Therapeutics's activity chart (see below) currently has 0 price targets and 6 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by KYLE ROSE from CANACCORD on 22-May-2019. First documented stock forecast 11-Nov-2016.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

4 years 10 months 28 days ago

0/1 (0%)

$6.83 (67.16%)

Hold

5 years 1 months 25 days ago

0/1 (0%)

$7.83 (76.99%)

Show more analysts

What is OBLN (Obalon Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on OBLN (Obalon Therapeutics) with a proven track record?

KYLE ROSE

Which analyst has the current lower performing score on OBLN (Obalon Therapeutics) with a proven track record?

RICK WISE

Which analyst has the most public recommendations on OBLN (Obalon Therapeutics)?

Kyle Rose works at CANACCORD and has 18 price targets and 11 ratings on OBLN

Which analyst is the currently most bullish on OBLN (Obalon Therapeutics)?

Rick Wise with highest potential upside - $0

Which analyst is the currently most reserved on OBLN (Obalon Therapeutics)?

Kyle Rose with lowest potential downside - -$0